about
An overview of cutaneous T cell lymphomasThe RhoA-ROCK pathway in the regulation of T and B cell responsesSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?ZEB1 regulates glioma stemness through LIF repression.Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndromeThe mutational landscape of cutaneous T cell lymphoma and Sézary syndromeCutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaMolecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesStaphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaGenomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesCD1d-restricted peripheral T cell lymphoma in mice and humans.Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides.PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeoverFunctional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies.Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.Sézary syndrome: old enigmas, new targets.Nonoverlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi.Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.The biomarker landscape in mycosis fungoides and Sézary syndrome.DNMT3A in Leukemia.Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.JAK inhibitors in dermatology: The promise of a new drug class.JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics.Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.Gene sharing between Epstein-Barr virus and human immune response genes.STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome.Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM).
P2860
Q26740306-18E9A382-6C9C-42E0-917C-09778A6AAA22Q28066137-7DF4A2EE-2C87-4286-BC69-FEB411F159ADQ30239965-09B8FFAF-7347-4136-9B34-05444CC682BBQ33669366-2F57F655-85D7-4269-AF16-F7547AA9213AQ33889309-CE18A53D-BAA1-4DB5-ACAA-F031DDAC6719Q34501143-84927F98-DAA2-4739-8282-AD644DFC5C35Q34516083-813AB335-C2F4-4002-925F-80F05E334C82Q36033609-3B57F618-CD61-4D27-9DD9-67BDA9264D12Q36191877-0CC43394-8AC4-4389-BA47-E00B9A4840B9Q36310531-3E543C36-62F4-4F15-B854-E033B1D905F7Q36372043-F5854840-AEA7-4108-8C8D-4C8DFE14A7F5Q36675064-1C11112E-17BD-409C-8301-800F0489FF86Q36793430-BBFEBECA-551D-470B-9EF7-E83FC3AF5BC5Q36863110-5CDB9200-5B91-449D-88D7-081E6FF9644EQ37262461-47F67D1A-56F4-4FFE-87CB-6527A255AF70Q37407941-792E52A4-B794-4DDC-BEF2-76B96E421F1FQ37633440-2EACBCDE-4B68-4E92-BBCC-D9520ED440CEQ37702571-1D2816BA-D785-4EAA-9077-B6EA3319CDC4Q37708848-9FFDEC10-751B-469C-AD33-9F484F5276AAQ37723390-CB09E72E-85F1-45A5-BAAA-8EAABFED9FADQ38677720-F530A215-3277-4FC6-A6DA-F07B199C054AQ38702312-A4467C08-EDF6-4921-8FD5-41ACD83E7C83Q38727148-069176BA-22AF-4FC9-BDC5-64CD9CBFFEC7Q38757938-E267C509-0DCC-412B-A9BA-983F3A6173FCQ38765889-587D0205-9B9C-446D-9007-7E26B95243AFQ38772711-5EC55DB9-6C91-4BE1-93E0-8E7F57001954Q38843246-AD46A426-A1B5-4316-A95A-ADB7644698E0Q38855013-32EA1951-7662-4588-B6A7-BF64514149F7Q39023382-BE4BD20F-88EF-4B4C-BC63-8387DBA833B6Q39047646-A019EB40-D77D-46CB-8EC5-DD60B9A1232AQ39055861-39DAB30F-6AA6-4E0B-AF4C-4DCB4EF16FA5Q39111032-F856CE96-0363-4F70-B263-C6EE39D1B48CQ39142126-57837EB3-CCCA-4A6B-ADEC-42F4CC52A3ABQ39926027-E41DB67B-8D6A-4CD0-A5D5-97E899585880Q40611888-DE4383F3-2815-42E7-8BAB-D58C30E23382Q40649135-D3BC4499-7CE4-4E92-B5CF-64F61BF5656DQ40802496-C727523A-E1B3-491B-8780-5B58A40B7E4AQ42365296-9264C30C-452C-4233-9A18-7D2CC8DA374BQ42580718-1E61426B-64E4-4FD6-8E45-8F29C76456E4Q45822425-ABB63D97-F968-42B2-ACE2-DAFBD8FBCE66
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genomic landscape of cutaneous T cell lymphoma.
@en
Genomic landscape of cutaneous T cell lymphoma.
@nl
type
label
Genomic landscape of cutaneous T cell lymphoma.
@en
Genomic landscape of cutaneous T cell lymphoma.
@nl
prefLabel
Genomic landscape of cutaneous T cell lymphoma.
@en
Genomic landscape of cutaneous T cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Genomic landscape of cutaneous T cell lymphoma.
@en
P2093
Antonio Subtil
Bok S Hong
Christopher G Bunick
David G Schatz
Eric C Vonderheid
Francine M Foss
Jesse Tordoff
John D Overton
Julia M Lewis
Kacie Carlson
P2860
P2888
P304
P356
10.1038/NG.3356
P407
P577
2015-07-20T00:00:00Z
P6179
1037288619